We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
ChemDiv to Provide Schering Plough Corporation with Discovery Libraries in Multiyear Agreement
News

ChemDiv to Provide Schering Plough Corporation with Discovery Libraries in Multiyear Agreement

ChemDiv to Provide Schering Plough Corporation with Discovery Libraries in Multiyear Agreement
News

ChemDiv to Provide Schering Plough Corporation with Discovery Libraries in Multiyear Agreement

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "ChemDiv to Provide Schering Plough Corporation with Discovery Libraries in Multiyear Agreement"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

ChemDiv announced today the continuation of multi-year collaboration with Schering Plough Corporation. In the framework of this collaboration ChemDiv will provide Schering Plough with a set of chemical libraries that will be produced through parallel synthesis based on the customer selected templates.

In accordance with the agreement teams of ChemDiv and Schering Plough scientists will work closely to develop exclusive small molecule libraries enhancing Schering Plough's global drug discovery effort. Further details and financial terms were not disclosed.

"ChemDiv is excited to be working with Schering Plough a pioneer of pharmaceutical industry that is working to improve people's health and extend lives. Their decision to select ChemDiv as their drug discovery partner underscores the quality of our work, the innovation we bring to our partners and our solid reputation for success in this field," said Nikolay Savchuk, President and CEO of ChemDiv.

"We are committed to expanding our product line to provide more integrated drug discovery services to our clients. We are now engaged in more discovery research programs than ever before, and we look forward to generating value on behalf of our clients."

Advertisement